November 3, 2003
IPA Conference – October 30 – November 1, 2003
Medical experts and patients are invited to attend the International Pompe Conference 2003. The goal of the conference is to
Genzyme General (Nasdaq: GENZ), a division of Genzyme Corp., announced today that it has treated the first patient in a
CAMBRIDGE, Mass – Genzyme General (Nasdaq: GENZ), a division of Genzyme Corp., announced today that it has begun enrolment in
December 2, 2002
Genzyme’s Pompe Program Update
An update by Genzyme regarding treatment for Pompe disease. Q: What is the status of the Pompe program? Genzyme has
October 2, 2002
IPA/Genzyme News—September 24, 2002
IBaarn, October 2nd 2002 Dear IPA members, Herewith I would like to inform you about the IPA/Genzyme telephone conference of